Medicare's Coverage of Tirzepatide

Medicare Part D covers tirzepatide, but only under specific conditions. The drug is approved for type 2 diabetes under the brand name Mounjaro and for weight management under the brand name Zepbound. Whether your plan covers it depends on which Part D plan you have, what tier the drug sits on, and whether your doctor's prescription meets the plan's requirements.

Most Part D plans do cover tirzepatide for diabetes, but many exclude it for weight loss alone. Even when covered, you may face a prior authorization requirement — your doctor must submit paperwork showing medical necessity before the pharmacy will fill the prescription. Some plans also require you to try and fail cheaper diabetes drugs first, a process called step therapy.

Original Medicare (Part A and Part B) does not cover tirzepatide at all. You must have Part D prescription coverage, either through a standalone Part D plan or a Medicare Advantage plan that includes drug coverage.

Key Takeaways

  • Tirzepatide for type 2 diabetes is covered by most Medicare Part D plans, but coverage for weight loss is rare and usually requires a specific diagnosis like obesity with a related health condition.
  • Your out-of-pocket cost depends on which tier your plan places tirzepatide on — typically $35 to $500+ per month depending on your plan and whether you have reached the coverage gap.
  • Your doctor will likely need to submit a prior authorization request before the pharmacy fills your prescription, which can add one to three business days.
  • You can check your specific plan's coverage by calling the plan's customer service number on your insurance card or logging into your plan's website.
  • If your current plan does not cover tirzepatide or charges too much, you can switch to a different Part D plan during the annual open enrollment period in October and November.

How Part D Plans Classify Tirzepatide

Part D plans organize drugs into tiers, and tirzepatide's tier determines what you pay. Most plans place tirzepatide on Tier 3 or Tier 4, which are higher tiers reserved for newer or more expensive drugs. A Tier 3 copay might be $50 to $100 per injection, while Tier 4 copays can reach $150 to $500 or more, depending on the plan.

Some plans use coinsurance instead of a flat copay, meaning you pay a percentage of the drug's cost — often 25 to 33 percent. Since tirzepatide costs around $1,000 per month before insurance, coinsurance can mean paying $250 to $330 monthly even with coverage.

A few plans may not cover tirzepatide at all, or may cover it only for diabetes and not for weight loss. You need to check your specific plan's formulary — the official list of covered drugs — to know where your plan places it.

Prior Authorization and Step Therapy Requirements

Most Medicare Part D plans require prior authorization for tirzepatide. Your doctor submits a form to the plan stating the diagnosis, why tirzepatide is medically necessary, and relevant test results like your A1C level for diabetes. The plan usually responds within one to three business days.

Some plans also impose step therapy, meaning your doctor must document that you tried and did not tolerate or did not respond to a cheaper drug first — usually a GLP-1 receptor agonist like semaglutide (Ozempic) or dulaglutide (Trulicity). If your doctor believes step therapy is inappropriate for your medical situation, they can request an exception, though this adds time.

Ask your doctor's office to handle the authorization request. They have the medical records and know the process. If the plan denies the request, you have the right to appeal, and your doctor can submit additional clinical information to support the appeal.

Tirzepatide for Weight Loss Versus Diabetes

Medicare's coverage differs sharply between the two uses. For type 2 diabetes, tirzepatide is covered by most Part D plans because it is an FDA-approved diabetes treatment. For weight loss alone — even obesity — coverage is much harder to find.

Some plans may cover tirzepatide for weight loss if you have obesity plus a related condition like heart disease, high blood pressure, or sleep apnea. You would need documentation from your doctor showing both the diagnosis and the medical reason tirzepatide is necessary. Even then, many plans deny these requests.

If your plan does not cover tirzepatide for weight loss, you have two options: pay out of pocket (around $1,000 per month), or ask your doctor whether a different GLP-1 drug like semaglutide might be covered instead. Some plans cover semaglutide for weight loss under certain conditions.

Checking Your Plan's Coverage

The fastest way to learn whether your plan covers tirzepatide is to call the customer service number on your Medicare insurance card. Have your prescription information ready — the drug name, dose, and frequency. Ask three things: Is tirzepatide on the formulary? What tier is it on? Does it require prior authorization?

You can also check online. Log into your plan's website and search the formulary by drug name. Most plans let you filter by indication (diabetes versus weight loss) and show the tier and any restrictions. If you cannot find the information online, call the plan.

If your plan does not cover tirzepatide or the cost is too high, you can switch plans. Open enrollment runs from October 15 to December 7 each year. You can change to a different Part D plan or switch to a Medicare Advantage plan with drug coverage. Compare plans at Medicare.gov using the Plan Finder tool.

What Happens if Your Plan Denies Coverage

If your plan denies the prior authorization, you receive a written notice explaining the reason. Common reasons include: the drug is not on the formulary, step therapy requirements were not met, or the plan determined the drug is not medically necessary for your diagnosis.

You have the right to appeal. Your doctor can submit additional clinical information, recent test results, or a letter explaining why step therapy is inappropriate. Appeals usually take five to seven business days. If the plan denies the appeal, you can request an independent review by an outside reviewer not employed by the plan.

While the appeal is pending, ask your doctor whether a covered alternative exists. Some plans cover other GLP-1 drugs or older diabetes medications that might work for you. Your doctor can also contact the plan directly to discuss your case — sometimes a conversation between providers moves the decision faster than paperwork alone.

Cost information Programs

If your Part D plan covers tirzepatide but the copay is high, you may be able to lower it. The manufacturer, Eli Lilly, offers a copay information program for Mounjaro (tirzepatide for diabetes) that can reduce your out-of-pocket cost to as little as $25 per month. You must meet income requirements, and the program does not work with all insurance plans, but it is worth checking.

You may also be may be able to access for the Part D Low-Income Subsidy (LIS) if your income and resources fall below certain thresholds. LIS covers most or all of your Part D costs, including copays and deductibles. You can check whether you may have access to by calling Social Security at 1-800-772-1213 or visiting your local Social Security office.

Some community health centers and pharmaceutical information programs also help uninsured or underinsured people access tirzepatide. Ask your doctor's office whether they know of any local programs.

Frequently Asked Questions

Does Medicare Part B cover tirzepatide injections?

No. Part B covers some injectable drugs, but tirzepatide is classified as a self-administered drug that you inject at home, so it falls under Part D prescription coverage instead. You need a Part D plan to have any Medicare coverage for tirzepatide.

Can I get tirzepatide covered for weight loss if I have diabetes?

It depends on your plan. If you have type 2 diabetes, most plans cover tirzepatide for that indication. If you want it for weight loss in addition to diabetes, some plans may cover both uses under one prescription, but you should confirm with your plan first. Many plans still restrict weight-loss coverage even for people with diabetes.

What if my doctor prescribes tirzepatide but my plan says it needs prior authorization?

Your doctor's office should submit the prior authorization request to your plan before you go to the pharmacy. This usually takes one to three business days. Do not fill the prescription until authorization is approved, or you may have to pay the full cost out of pocket.

Can I switch Medicare plans to get tirzepatide coverage?

Yes, during the annual open enrollment period from October 15 to December 7. You can switch to a different Part D plan or a Medicare Advantage plan that covers tirzepatide on a lower tier or without step therapy. Use the Plan Finder tool at Medicare.gov to compare plans in your area.

What is the difference between Mounjaro and Zepbound?

Both contain tirzepatide, but Mounjaro is approved for type 2 diabetes and Zepbound is approved for weight loss. Medicare Part D plans are more likely to cover Mounjaro. If your doctor prescribes Zepbound for weight loss, your plan may deny it even though it is the same drug under a different brand name.